< Back to all Breaking News
AKTX
5/29/2020 07:05am
Akari Therapeutics sees site initiations delayed for Phase III trial in HSCT-TMA 
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
